Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 222-733-7 | CAS number: 3590-84-9
Endpoint summary
Administrative data
Description of key information
A guideline 28-day subacute dietary study conducted in Wistar rats was identified as the key study.
Based on the observed effects in the high-dose animals, decrease in thymus weight (male and female animals) and microscopic findings in the thymus (female animals), the No Observed Adverse Effect Level (NOAEL) for general toxicity is established at the mid-dose level (1500 mg/kg diet which is equivalent to 86-99 mg/kg body weight/day for the male animals and to 80-141 mg/kg body weight/day for the female animals.
Key value for chemical safety assessment
Repeated dose toxicity: via oral route - systemic effects
Endpoint conclusion
- Dose descriptor:
- NOAEL
- 80 mg/kg bw/day
- Study duration:
- subacute
- Species:
- rat
Additional information
A guideline 28-day subacute dietary study conducted in Wistar rats was identified as the key study.
The objective of this study was to provide data on the possible reproductive and developmental effects of tetraoctylstannane [CAS # 3590-84-9] after oral administration via the diet to Wistar rats of both sexes. The study was combined with a repeated dose toxicity study, rats were fed diets containing 0, 100, 500, 2000 and 10,000 mg/tetraoctylstannane/kg diet for 14 days. In the main study, rats were fed diets containing 0, 500, 1500, 7500 mg tetraoctylstannane/ kg diet for up to 33 days (males) or during 2 weeks premating, mating, gestation and up to day 4 or 5 of lactation (females).
No treatment-related mortalities or clinical signs were observed.
Based on the observed effects in the high-dose animals, decrease in thymus weight (male and female animals) and microscopic findings in the thymus (female animals), the No Observed Adverse Effect Level (NOAEL) for general toxicity is established at the mid-dose level (1500 mg/kg diet which is equivalent to 86-99 mg/kg body weight/day for the male animals and to 80-141 mg/kg body weight/day for the female animals.
Repeated dose toxicity: via oral route - systemic effects (target organ) glandular: thyroids
Justification for classification or non-classification
Based upon the information presented in this study, with the NOAEL established as being below 150 mg/kg/bw day in a subacute study, it is considered that the substance is classified as R48/22 Harmful: danger of serious damage to health by prolonged exposure in accordance with Directive 67/548/EEC and as STOT category 2 after repeat exposure (H373) in accordance with Regulation (EC) No 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
